Literature DB >> 7669826

Effect of neuroleptics on phospholipase A2 activity in the brain of rats.

H I Trzeciak1, W Kalaciński, A Małecki, D Kokot.   

Abstract

The effect of neuroleptics on phospholipase A2 (PLA2) activity in rat brain plasma membranes was studied. Chlorpromazine (10 mg/kg), fluphenazine (5 mg/kg), thioridazine (5 mg/kg), trifluoperazine (5 mg/kg), haloperidol (2 mg/kg), and sulpiride (100 mg/kg) were administered to rats intraperitoneally as a single dose or long-term treatment (4 weeks). The PLA2 activity was determined 24, 48, and 72 h after the last injection of a drug. The enzyme activity was decreased after a single or 4-week administration of chlorpromazine, trifluoperazine, haloperidol, and sulpiride. Fluphenazine and thioridazine caused an increase of PLA2 activity in rat brain both after a single dose and long-term administration. For the first time it was shown that neuroleptics cannot only inhibit but also increase, PLA2 activity. Elucidation of this fact requires further studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669826     DOI: 10.1007/bf02193092

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  26 in total

1.  Light activation of phospholipase A2 in rod outer segments of bovine retina and its modulation by GTP-binding proteins.

Authors:  C L Jelsema
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

2.  Local anesthetics, chlorpromazine and propranolol inhibit stimulus-activation of phospholipase A2 in human platelets.

Authors:  J Y Vanderhoek; M B Feinstein
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

3.  Increased serum phospholipase A2 activity in schizophrenia: a replication study.

Authors:  W F Gattaz; C V Hübner; T J Nevalainen; T Thuren; P K Kinnunen
Journal:  Biol Psychiatry       Date:  1990-09-15       Impact factor: 13.382

4.  Guanine nucleotides and fluoride enhance carbachol-mediated arachidonic acid release from phosphatidylinositol. Evidence for involvement of GTP-binding protein in phospholipase A2 activation.

Authors:  J Strosznajder; R P Strosznajder
Journal:  J Lipid Mediat       Date:  1989 Jul-Aug

5.  Increased platelet phospholipase A2 activity in schizophrenia.

Authors:  W F Gattaz; A Schmitt; A Maras
Journal:  Schizophr Res       Date:  1995-07       Impact factor: 4.939

6.  Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.

Authors:  W F Gattaz; M Köllisch; T Thuren; J A Virtanen; P K Kinnunen
Journal:  Biol Psychiatry       Date:  1987-04       Impact factor: 13.382

7.  Phospholipase A2 activity in serum of neuroleptic-naive psychiatric inpatients.

Authors:  M Albers; H Meurer; F Märki; J Klotz
Journal:  Pharmacopsychiatry       Date:  1993-05       Impact factor: 5.788

8.  Effects of various drugs on superoxide generation, arachidonic acid release and phospholipase A2 in polymorphonuclear leukocytes.

Authors:  K Taniguchi; M Urakami; K Takanaka
Journal:  Jpn J Pharmacol       Date:  1988-03

9.  Action of phospholipase A2 of rabbit neuronal and glial cells on 1,2-diacyl-, 2-acyl-1-alk-1'-enyl-, and 2-acyl-1-alkyl-glycerophosphatides.

Authors:  H Woelk; G Arienti; A Gaiti; K Kanig; G Porcellati
Journal:  Neurochem Res       Date:  1981-01       Impact factor: 3.996

10.  Role of phospholipids in coupling of adenosine and dopamine receptors to striatal adenylate cyclase.

Authors:  M B Anand-Srivastava; R A Johnson
Journal:  J Neurochem       Date:  1981-05       Impact factor: 5.372

View more
  7 in total

1.  Chronic lithium treatment decreases brain phospholipase A2 activity.

Authors:  M C Chang; C R Jones
Journal:  Neurochem Res       Date:  1998-06       Impact factor: 3.996

2.  Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment.

Authors:  M C Chang; J M Bell; A D Purdon; E G Chikhale; E Grange
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

3.  Antidepressant drugs diversely affect autophagy pathways in astrocytes and neurons--dissociation from cholesterol homeostasis.

Authors:  Jürgen Zschocke; Nicole Zimmermann; Barbara Berning; Vanessa Ganal; Florian Holsboer; Theo Rein
Journal:  Neuropsychopharmacology       Date:  2011-04-20       Impact factor: 7.853

4.  Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications.

Authors:  Robert K McNamara; Ronald Jandacek; Therese Rider; Patrick Tso; Chang-Gyu Hahn; Neil M Richtand; Kevin E Stanford
Journal:  Schizophr Res       Date:  2007-01-19       Impact factor: 4.939

5.  Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis.

Authors:  Robert K McNamara; Jessica A Able; Ronald Jandacek; Therese Rider; Patrick Tso
Journal:  Schizophr Res       Date:  2008-11-07       Impact factor: 4.939

6.  Platelet phospholipase A2 activity in patients with Alzheimer's disease, vascular dementia and ischemic stroke.

Authors:  E Krzystanek; M Krzystanek; G Opala; H I Trzeciak; J Siuda; A Małecki
Journal:  J Neural Transm (Vienna)       Date:  2007-04-20       Impact factor: 3.575

7.  Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity.

Authors:  Marek Krzystanek; Ewa Krzystanek; Katarzyna Skałacka; Artur Pałasz
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.